TP53 and hematopoietic and lymphoid system neoplasm: It has previously been reported in human blood cancer, colon cancer, and osteosarcoma that p53 stimulated the MAPK/ERK pathway, protecting the cancerous cells from p53-dependent apoptosis [15,16].